Combined COVID-19, Flu Vaccine Candidate Headed to Phase 3 Trials

JAMA. 2023 Dec 5;330(21):2044. doi: 10.1001/jama.2023.22353.
No abstract available

Publication types

  • Clinical Trial, Phase III

MeSH terms

  • Antibodies, Viral
  • COVID-19 Vaccines* / administration & dosage
  • COVID-19 Vaccines* / therapeutic use
  • COVID-19* / prevention & control
  • Humans
  • Influenza Vaccines* / administration & dosage
  • Influenza Vaccines* / therapeutic use
  • Influenza, Human* / prevention & control
  • Vaccination
  • Vaccines, Combined* / administration & dosage
  • Vaccines, Combined* / therapeutic use

Substances

  • Antibodies, Viral
  • Influenza Vaccines
  • COVID-19 Vaccines
  • Vaccines, Combined